PATH (Peer Advanced Training in Harm Reduction) to Reducing Burnout Among Peers Who Deliver Harm Reduction Services (R61 Phase Pilot)
NCT ID: NCT07218562
Last Updated: 2025-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE2
100 participants
INTERVENTIONAL
2026-01-15
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peer Support Workers Feasibility Study
NCT07030192
Reducing Drug Use in Justice-Involved Emerging Adults
NCT05834881
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
NCT05700994
Cognitive Training in Inpatient Treatment for Substance Use Disorders
NCT02356718
Nursing Attitudes Towards SUD
NCT05218681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PATH will include 3 hours of eLearning modules and 8 weekly ECHO (Extension for Community Health Outcomes) meetings lasting 1.5 hours each, delivered over 2 months. Each ECHO session includes a 30-minute presentation followed by one hour of case-based discussion about a real client or problem. The full PATH intervention will take 15 hours (3 hours of eLearning and 12 hours of ECHO participation) over 3 months. Participants are expected to complete all 15 hours, completing the 3 hours of eLearning before starting the 12 hours of ECHO activities.
The investigators will administer the PATH components with the PRSS and administrators/supervisors from two RCOs, while assessing the duration and dose of an individual participant's engagement by tracking eLearning module completion and ECHO attendance. Voluntary survey and qualitative data collection will be used to assess the primary measures for this pilot. Data collection will also assess training satisfaction and changes in burnout, compassion satisfaction, secondary trauma, and HR knowledge, attitudes, and skills.
Participants of the PATH pilot will be invited to complete surveys at three timepoints. The baseline survey will be distributed immediately prior to beginning the PATH training activities. Measures on the baseline survey will include demographics, burnout, compassion satisfaction, secondary trauma, and HR knowledge, attitudes, and skills. Following the completion of the eLearning components of the training (approximately 1 month post-initiation), the second survey will be distributed to all participants. Measures on the survey will include acceptability, appropriateness, and feasibility of the training component, as well as training satisfaction. Finally, following completion of the final ECHO meeting (approximately 3 months post-initiation), the third survey will be distributed to all participants. All measures from the first two surveys will be included in the final survey, excluding demographics. All surveys will be collected in REDCap. Personalized survey links will be sent directly to each participant's email address. Each survey will take approximately 15-30 minutes to complete. Additionally, the investigators will track and obtain administrative training data for the eLearning modules and ECHO meetings, including engagement and attendance.
PRSS staff participants will also be invited to complete a final qualitative focus group regarding their participation in the PATH training activities. Depending on the final number of participants per RCO, investigators will conduct 1-2 focus groups for each site. Each focus group will last approximately 60-90 minutes and be conducted via Zoom teleconference. Questions will focus on participants' experiences with the PATH training activities, particularly regarding the content, clarity, applicability, relevance, and usefulness of both the eLearning modules and ECHO meetings. Additionally, participants will be asked about barriers and facilitators to completing the PATH training activities and suggestions for improvement. Similarly, the administrator/supervisor will be invited to complete a final qualitative interview regarding their organization's participation in the PATH training activities. The interview will last approximately 45-60 minutes and be conducted via Zoom teleconference. Questions will focus on the administrator's opinions of staff experiences with the PATH training activities, particularly regarding the applicability, relevance, and usefulness of both the eLearning modules and ECHO meetings, as well as the impact of the training on their team. Administrators/supervisors will be asked about barriers and facilitators to having their staff complete the PATH training activities and suggestions for improvement.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PATH pilot participants
Receive PATH pilot intervention
PATH (Peer Advanced Training in Harm reduction)
PATH is an educational workforce intervention for improving peer recovery support specialists' (PRSS) harm reduction (HR) service delivery ability and quality and as a PRSS workforce and service system support. PATH will include 3 hours of eLearning modules and 8 weekly ECHO (Extension for Community Health Outcomes) meetings lasting 1.5 hours each, delivered over 2 months. Each ECHO session includes a 30-minute presentation followed by one hour of case-based discussion about a real client or problem. The entire PATH intervention will take 15 hours (3 hours of eLearning and 12 hours of ECHO participation) over 3 months. Participants are expected to complete all 15 hours, completing the 3 hours of eLearning before starting the 12 hours of ECHO activities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PATH (Peer Advanced Training in Harm reduction)
PATH is an educational workforce intervention for improving peer recovery support specialists' (PRSS) harm reduction (HR) service delivery ability and quality and as a PRSS workforce and service system support. PATH will include 3 hours of eLearning modules and 8 weekly ECHO (Extension for Community Health Outcomes) meetings lasting 1.5 hours each, delivered over 2 months. Each ECHO session includes a 30-minute presentation followed by one hour of case-based discussion about a real client or problem. The entire PATH intervention will take 15 hours (3 hours of eLearning and 12 hours of ECHO participation) over 3 months. Participants are expected to complete all 15 hours, completing the 3 hours of eLearning before starting the 12 hours of ECHO activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* current PRSS staff or administrator involved in HR service delivery
* is at least 18 years of age.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Chestnut Health Systems
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dennis Watson
Senior Research Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dennis P Watson, PhD
Role: PRINCIPAL_INVESTIGATOR
Chestnut Health Systems
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chestnut Health Systems Lighthouse Institute
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.